China National Medicines Corporation Ltd. (600511.SS)
CNY 31.16
(0.1%)
CNY 31.16
(0.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.85 Billion CNY | -2.22% |
| 2022 | 3.82 Billion CNY | 5.26% |
| 2021 | 3.63 Billion CNY | 15.54% |
| 2020 | 3.14 Billion CNY | -19.57% |
| 2019 | 3.9 Billion CNY | 14.29% |
| 2018 | 3.41 Billion CNY | 20.64% |
| 2017 | 2.83 Billion CNY | 185.15% |
| 2016 | 993.86 Million CNY | 3.49% |
| 2015 | 960.3 Million CNY | 5.24% |
| 2014 | 912.46 Million CNY | 22.18% |
| 2013 | 746.81 Million CNY | 31.49% |
| 2012 | 567.97 Million CNY | 26.35% |
| 2011 | 449.52 Million CNY | -14.06% |
| 2010 | 523.05 Million CNY | 12.67% |
| 2009 | 464.23 Million CNY | 14.17% |
| 2008 | 406.62 Million CNY | 10.93% |
| 2007 | 366.55 Million CNY | 43.04% |
| 2006 | 256.26 Million CNY | 24.94% |
| 2005 | 205.11 Million CNY | 13.23% |
| 2004 | 181.14 Million CNY | 13.2% |
| 2003 | 160.01 Million CNY | 20.52% |
| 2002 | 132.76 Million CNY | 14.81% |
| 2001 | 115.63 Million CNY | 2.8% |
| 2000 | 112.48 Million CNY | 19.71% |
| 1999 | 93.96 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 830.39 Million CNY | -2.55% |
| 2024 Q1 | 852.08 Million CNY | -22.14% |
| 2024 Q3 | 915.67 Million CNY | 10.27% |
| 2023 Q2 | 1 Billion CNY | 15.85% |
| 2023 Q1 | 864.49 Million CNY | -14.89% |
| 2023 FY | 3.73 Billion CNY | -2.22% |
| 2023 Q4 | 1.09 Billion CNY | 13.81% |
| 2023 Q3 | 961.55 Million CNY | -3.99% |
| 2022 Q3 | 1.08 Billion CNY | 17.69% |
| 2022 Q1 | 793.3 Million CNY | -18.49% |
| 2022 Q4 | 1.01 Billion CNY | -6.68% |
| 2022 FY | 3.82 Billion CNY | 5.26% |
| 2022 Q2 | 924.77 Million CNY | 16.57% |
| 2021 Q3 | 1.01 Billion CNY | 5.25% |
| 2021 FY | 3.63 Billion CNY | 15.54% |
| 2021 Q2 | 963.88 Million CNY | 41.85% |
| 2021 Q1 | 679.48 Million CNY | -21.56% |
| 2021 Q4 | 973.21 Million CNY | -4.07% |
| 2020 Q2 | 809.92 Million CNY | 47.73% |
| 2020 Q4 | 866.27 Million CNY | -5.67% |
| 2020 FY | 3.14 Billion CNY | -19.57% |
| 2020 Q1 | 548.26 Million CNY | -54.39% |
| 2020 Q3 | 918.33 Million CNY | 13.38% |
| 2019 Q2 | 1.01 Billion CNY | 30.23% |
| 2019 Q1 | 776.08 Million CNY | -13.34% |
| 2019 Q4 | 1.2 Billion CNY | 30.81% |
| 2019 FY | 3.9 Billion CNY | 14.29% |
| 2019 Q3 | 918.85 Million CNY | -9.09% |
| 2018 Q2 | 946.26 Million CNY | 22.71% |
| 2018 Q3 | 806.12 Million CNY | -14.81% |
| 2018 Q1 | 771.13 Million CNY | -13.89% |
| 2018 Q4 | 895.57 Million CNY | 11.1% |
| 2018 FY | 3.41 Billion CNY | 20.64% |
| 2017 Q4 | 895.55 Million CNY | 26.03% |
| 2017 Q1 | 266.12 Million CNY | 12.61% |
| 2017 Q2 | 961.72 Million CNY | 261.38% |
| 2017 Q3 | 710.61 Million CNY | -26.11% |
| 2017 FY | 2.83 Billion CNY | 185.15% |
| 2016 FY | 993.86 Million CNY | 3.49% |
| 2016 Q2 | 250.49 Million CNY | 3.41% |
| 2016 Q1 | 242.24 Million CNY | 5.39% |
| 2016 Q4 | 236.33 Million CNY | -10.75% |
| 2016 Q3 | 264.79 Million CNY | 5.71% |
| 2015 Q4 | 229.86 Million CNY | -14.18% |
| 2015 FY | 960.3 Million CNY | 5.24% |
| 2015 Q3 | 267.83 Million CNY | 6.04% |
| 2015 Q2 | 252.57 Million CNY | 20.25% |
| 2015 Q1 | 210.03 Million CNY | -3.62% |
| 2014 FY | 912.46 Million CNY | 22.18% |
| 2014 Q2 | 269.58 Million CNY | 44.96% |
| 2014 Q1 | 185.96 Million CNY | 8.43% |
| 2014 Q4 | 217.91 Million CNY | -8.82% |
| 2014 Q3 | 238.98 Million CNY | -11.35% |
| 2013 Q3 | 233.74 Million CNY | 24.86% |
| 2013 Q2 | 187.21 Million CNY | 21.29% |
| 2013 Q1 | 154.34 Million CNY | 7.06% |
| 2013 FY | 746.81 Million CNY | 31.49% |
| 2013 Q4 | 171.51 Million CNY | -26.62% |
| 2012 Q4 | 144.17 Million CNY | -11.62% |
| 2012 Q1 | 132.8 Million CNY | 167.24% |
| 2012 Q2 | 127.88 Million CNY | -3.71% |
| 2012 Q3 | 163.12 Million CNY | 27.56% |
| 2012 FY | 567.97 Million CNY | 26.35% |
| 2011 FY | 449.52 Million CNY | -14.06% |
| 2011 Q1 | 131.85 Million CNY | 15.91% |
| 2011 Q4 | 49.69 Million CNY | -64.23% |
| 2011 Q3 | 138.94 Million CNY | 7.69% |
| 2011 Q2 | 129.02 Million CNY | -2.15% |
| 2010 Q4 | 113.75 Million CNY | -23.4% |
| 2010 FY | 523.05 Million CNY | 12.67% |
| 2010 Q3 | 148.51 Million CNY | 14.6% |
| 2010 Q2 | 129.59 Million CNY | -1.22% |
| 2010 Q1 | 131.18 Million CNY | 22.29% |
| 2009 Q1 | 115.78 Million CNY | 14.83% |
| 2009 Q4 | 107.27 Million CNY | -12.26% |
| 2009 FY | 464.23 Million CNY | 14.17% |
| 2009 Q3 | 122.26 Million CNY | 2.83% |
| 2009 Q2 | 118.9 Million CNY | 2.7% |
| 2008 FY | 406.62 Million CNY | 10.93% |
| 2008 Q4 | 100.82 Million CNY | 1.21% |
| 2008 Q3 | 99.62 Million CNY | 2.45% |
| 2008 Q2 | 97.24 Million CNY | -10.73% |
| 2008 Q1 | 108.93 Million CNY | 12.98% |
| 2007 Q4 | 96.41 Million CNY | -3.93% |
| 2007 Q1 | 84.9 Million CNY | 52.95% |
| 2007 Q2 | 84.87 Million CNY | -0.04% |
| 2007 FY | 366.55 Million CNY | 43.04% |
| 2007 Q3 | 100.36 Million CNY | 18.25% |
| 2006 Q1 | 64.7 Million CNY | 27.96% |
| 2006 FY | 256.26 Million CNY | 24.94% |
| 2006 Q4 | 55.51 Million CNY | -18.87% |
| 2006 Q3 | 68.42 Million CNY | 1.19% |
| 2006 Q2 | 67.62 Million CNY | 4.51% |
| 2005 FY | 205.11 Million CNY | 13.23% |
| 2005 Q4 | 50.56 Million CNY | -6.02% |
| 2005 Q1 | 53.53 Million CNY | 19.92% |
| 2005 Q3 | 53.8 Million CNY | 13.98% |
| 2005 Q2 | 47.2 Million CNY | -11.82% |
| 2004 Q4 | 44.64 Million CNY | -6.92% |
| 2004 Q3 | 47.96 Million CNY | 10.74% |
| 2004 FY | 181.14 Million CNY | 13.2% |
| 2004 Q2 | 43.3 Million CNY | -4.25% |
| 2004 Q1 | 45.22 Million CNY | 3.41% |
| 2003 Q2 | 37.78 Million CNY | -1.37% |
| 2003 Q1 | 38.31 Million CNY | 9.05% |
| 2003 FY | 160.01 Million CNY | 20.52% |
| 2003 Q4 | 43.73 Million CNY | 8.86% |
| 2003 Q3 | 40.17 Million CNY | 6.31% |
| 2002 Q4 | 35.13 Million CNY | 1.2% |
| 2002 Q3 | 34.71 Million CNY | -3.68% |
| 2002 FY | 132.76 Million CNY | 14.81% |
| 2002 Q2 | 36.04 Million CNY | 34.13% |
| 2002 Q1 | 26.87 Million CNY | 0.0% |
| 2001 FY | 115.63 Million CNY | 2.8% |
| 2000 FY | 112.48 Million CNY | 19.71% |
| 1999 FY | 93.96 Million CNY | 0.0% |